These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32908944)

  • 21. Outcomes of ceftriaxone use compared to standard of therapy in methicillin susceptible staphylococcal aureus (MSSA) bloodstream infections.
    Patel UC; McKissic EL; Kasper D; Lentino JR; Pachucki CT; Lee T; Lopansri BK
    Int J Clin Pharm; 2014 Dec; 36(6):1282-9. PubMed ID: 25186790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta-analysis.
    Yetmar ZA; Razi S; Nayfeh T; Gerberi DJ; Mahmood M; Abu Saleh OM
    Int J Antimicrob Agents; 2022 Jan; 59(1):106486. PubMed ID: 34839007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does the Beta-Lactam Matter? Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections.
    Burrelli CC; Broadbent EK; Margulis A; Snyder GM; Gold HS; McCoy C; Mahoney MV; Hirsch EB
    Chemotherapy; 2018; 63(6):345-351. PubMed ID: 30965335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Gern BH; Greninger AL; Weissman SJ; Stapp JR; Tao Y; Qin X
    Ann Clin Microbiol Antimicrob; 2018 Feb; 17(1):5. PubMed ID: 29463249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftriaxone versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia.
    Mohamed A; Bennett N; Ploetz J; Aragon L; Kennedy K; Boyd S
    Int J Antimicrob Agents; 2022 Sep; 60(3):106632. PubMed ID: 35787919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study.
    Lefèvre B; Hoen B; Goehringer F; Sime WN; Aissa N; Alauzet C; Jeanmaire E; Hénard S; Filippetti L; Selton-Suty C; Agrinier N;
    Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2605-2616. PubMed ID: 34383175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia.
    Twilla JD; Algrim A; Adams EH; Samarin M; Cummings C; Finch CK
    Am J Med Sci; 2020 Jul; 360(1):35-41. PubMed ID: 32376001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.
    Agnello S; Wardlow LC; Reed E; Smith JM; Coe K; Day SR
    Int J Antimicrob Agents; 2021 Aug; 58(2):106363. PubMed ID: 34033912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting.
    Youngster I; Shenoy ES; Hooper DC; Nelson SB
    Clin Infect Dis; 2014 Aug; 59(3):369-75. PubMed ID: 24785233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial.
    Cheng MP; Lawandi A; Butler-Laporte G; De l'Étoile-Morel S; Paquette K; Lee TC
    Clin Infect Dis; 2021 May; 72(9):e196-e203. PubMed ID: 32667982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus.
    Wynn M; Dalovisio JR; Tice AD; Jiang X
    South Med J; 2005 Jun; 98(6):590-5. PubMed ID: 16004164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
    Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW
    Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.
    Pollett S; Baxi SM; Rutherford GW; Doernberg SB; Bacchetti P; Chambers HF
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4684-9. PubMed ID: 27216053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative outcomes of cefazolin versus antistaphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post hoc analysis of a prospective multicentre French cohort study.
    Lecomte R; Bourreau A; Deschanvres C; Issa N; Le Turnier P; Gaborit B; Chauveau M; Leroy AG; Le Tourneau T; Caillon J; Camou F; Boutoille D
    Clin Microbiol Infect; 2021 Jul; 27(7):1015-1021. PubMed ID: 32950711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftriaxone as an Alternative Therapy for the Treatment of Methicillin-Susceptible
    Barber KE; Cramer RA; Bell AM; Wagner JL; Stover KR
    Case Rep Infect Dis; 2021; 2021():8884685. PubMed ID: 33986964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the Surrogate Susceptibility of Oxacillin and Cefoxitin for Commonly Utilized Parenteral Agents against Methicillin-Susceptible Staphylococcus aureus: Focus on Ceftriaxone Discordance between Predictive Susceptibility and in Vivo Exposures.
    Kang N; Housman ST; Nicolau DP
    Pathogens; 2015 Jul; 4(3):599-605. PubMed ID: 26264030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.
    Li J; Echevarria KL; Traugott KA
    Pharmacotherapy; 2017 Mar; 37(3):346-360. PubMed ID: 28035690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible
    Uda A; Onuma K; Shigemura K; Kitagawa K; Yan Y; Osawa K; Yano I; Miyara T
    Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nationwide Organism Susceptibility Patterns to Common Preoperative Prophylactic Antibiotics: What Are We Covering?
    Nodzo SR; Boyle KK; Frisch NB
    J Arthroplasty; 2019 Jul; 34(7S):S302-S306. PubMed ID: 30745218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-Susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable
    Jones D; Elshaboury RH; Munson E; Dilworth TJ
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038267
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.